U.S. Alzheimer’s Drugs Market Size, Share, Report 2024-2032

Rahul Kumar12 Feb, 2025Business

Alzheimer's drugs are pharmaceutical compounds and therapies specifically formulated to alleviate symptoms or decelerate the progression of this prevalent neurodegenerative disorder that predominantly impacts cognitive functions. They are designed to target the fundamental pathophysiological changes occurring in the brain, including the build-up of amyloid plaques and tau tangles, distinctive features of Alzheimer's disease.